NEWARK, Del.--(BUSINESS WIRE)--Aug. 28, 2006--Strategic Diagnostics Inc. (Nasdaq:SDIX) and Broin and Associates, Inc., a division of the Broin Companies, today announced the signing of a contract to develop application(s) based on SDI’s patent-pending technology utilizing bacteriophage as selective agents. The application(s) will directly support Broin and Associates proprietary BPX technologies for ethanol production. Terms of the agreement were not disclosed.
